Alaya.bio
PrivateLast Round
Series A
Jul 10, 2026
Total Funding Raised
$9.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Alaya.bio is a biotechnology company developing a proprietary polymeric nanoparticle platform for in-vivo CAR-T cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alaya.bio Comparables
Compare Alaya.bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aera Therapeutics | 86% | |
| Abintus Bio | 82% | |
| Ensoma | 82% |
Alaya.bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 10, 2026 | ||||
| Seed | Dec 1, 2022 | ||||
| Pre Seed | Aug 8, 2022 |
Alaya.bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agoranov | Seed |
| Mission BioCapital | Pre Seed |
| Volnay Therapeutics | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 10, 2026
Raised $10.9M pre-money valuation.
- Aug 8, 2022
$3M round led by Mission BioCapital and Volnay Therapeutics.
Alaya.bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alaya.bio's valuation, stock price, and market status.
Is Alaya.bio a public or private company?
Alaya.bio is a private company.
What is the current stock price of Alaya.bio?
Alaya.bio is a private company with no public stock price. No recent secondary market data is available.
How much is Alaya.bio worth (valuation)?
Valuation information for Alaya.bio is not publicly available.
Can I buy Alaya.bio stock?
Alaya.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Alaya.bio's last funding round?
Alaya.bio's most recent funding round was Seed on December 1, 2022.
Who are the main investors in Alaya.bio?
Key investors in Alaya.bio include Agoranov, Volnay Therapeutics.
Will Alaya.bio IPO soon?
No public IPO plans have been announced for Alaya.bio.
How can I track Alaya.bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alaya.bio's secondary market activity and sign up for updates.